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SUMMARY 37 
Setting: Academic tertiary referral hospital in Durban, South Africa  38 
Objective: To describe the incidence and diagnostic challenges of TB in HIV-infected children 39 
with severe acute malnutrition (SAM) 40 
Design: Post-hoc analysis of a randomised controlled trial that enrolled ART-naïve, HIV-41 
infected children with SAM. Trial records and hospital laboratory results were explored for 42 
clinical diagnoses and bacteriologically confirmed cases of TB.  Negative binomial regression 43 
was used to explore associations with confirmed cases of TB, excluding cases where the 44 
clinical diagnosis was not supported by microbiological confirmation.   45 
Results: Of 82 children enrolled in the study, 21 (25.6%) were diagnosed with TB, with 46 
bacteriological confirmation in 8 cases.  Sputum sampling (as opposed to gastric washings) 47 
was associated with an increased risk of subsequent diagnosis of TB (adjusted relative risk 48 
1.134, 95% CI 2.1%—26%).  A culture-proven bacterial infection during the admission was 49 
associated with a reduced risk of TB (aRR 0.856, 0.748—0.979), which may reflect false 50 
negative microbiologic tests secondary to empiric broad spectrum antibiotics.   51 
Conclusion: TB is common in HIV-infected children with SAM.  While microbiological 52 
confirmation of the diagnosis is feasible, empiric treatment remains common, possibly 53 
influenced by suboptimal testing and false negative TB diagnostics.  Rigorous microbiological 54 
TB investigation should be integrated into the programmatic management of HIV and SAM.   55 
  56 
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INTRODUCTION 57 
Tuberculosis (TB), HIV infection and severe acute malnutrition (SAM) are individually 58 
responsible for high levels of morbidity and mortality among children across sub-Saharan 59 
Africa.  Research is ongoing into how these three interact, although the potency of the 60 
combination has been recognised for some time.
1
   61 
Over 650,000 cases of paediatric TB occur annually in the 22 highest-burden countries,
2
 62 
resulting in an estimated 140,000 annual deaths.
3
 Over 2.6 million children across the world 63 
are living with HIV, with 90% of these living in sub-Saharan Africa.
4
  HIV was responsible for 64 
150,000 childhood deaths in 2014.  SAM—incorporating marasmus, kwashiorkor and 65 
marasmic kwashiorkor—is responsible for as much as 10% of all global mortality in children 66 
aged <5 years,
5
 with marasmus alone accounting for over 500,000 deaths annually in this 67 
age group.
6
   68 
In South Africa, over 36,000 cases of childhood TB occur annually, one quarter of which are 69 
believed to be HIV co-infected.
7,8
  HIV is responsible for 17% of all deaths in South African 70 
children aged under 5 years.
8
  One study found that 10% of children initiating antiretroviral 71 
therapy (ART) in rural South Africa also had SAM.
9
  72 
While SAM combined with HIV has already been recognised as a challenging clinical entity, 73 
associated with increased mortality,
10,11
 the contribution of TB in this scenario is uncertain.  74 
Malnutrition is associated with increased mortality in paediatric TB,
12
 particularly with HIV 75 
co-infection
13
. TB causes cachexia and wasting, and may itself be impacted by poor 76 
nutritional status.
14,15
 HIV is an independent risk factor for both TB and malnutrition, 77 
worsening the outcomes of either condition.
10,16
 The spectrum of TB in a cohort of 78 
paediatric patients who all have the specific combination of both HIV and SAM has not yet 79 
been studied. A randomised controlled trial (Malnutrition and Antiretroviral Timing in 80 
Children with HIV, MATCH) assessing the clinical and pharmacokinetic responses to early 81 
versus delayed ART in HIV-infected children with SAM was conducted in Durban, South 82 
Africa. 
17
 We present a post-hoc analysis of TB diagnoses in these patients.  83 
 84 
 85 
Page 3 of 22
For Review Only
4 
 
STUDY POPULATION AND METHODS 86 
Setting 87 
King Edward VIII Hospital (KEH) in Durban, South Africa has a 100-bed paediatric ward, 88 
including 10 nutritional rehabilitation beds, providing regional tertiary-level care.   89 
Recruitment and eligibility 90 
All children presenting with SAM and newly diagnosed with HIV were eligible for inclusion in 91 
the trial, and randomised either to early (within ten days of admission) or delayed (at four 92 
weeks or at protocol-defined nutritional recovery) ART.
17
  Recruitment was carried out 93 
between 2012 and 2014.  All children eligible for inclusion in the MATCH trial were eligible 94 
for inclusion in this retrospective analysis.   95 
SAM was defined as weight-for-height z score below -3 standard deviations from the World 96 
Health Organisation (WHO) median or a mid-upper-arm circumference of <115mm, with or 97 
without bilateral oedema
18
 and was managed according to the latest WHO guidelines.
19
    98 
Patients were classified as bacteriologically confirmed TB (based on positive sputum smear 99 
microscopy, mycobacterial culture or nucleic acid amplification), clinically diagnosed 100 
(empirically treated) TB, or no TB, as per the WHO.
20
  A more detailed classification of 101 
clinically-diagnosed cases was not possible, as patients’ original files and radiographs were 102 
frequently unavailable.   103 
Data collection 104 
We retrospectively searched the National Health Laboratory Service’s laboratory 105 
information management system for TB diagnostic test results from all patients in the 106 
MATCH trial, from the date of admission with SAM to any hospital in Durban, through to 107 
one month after transfer to KEH and enrolment in the study. We also recorded routine 108 
biochemical, haematological and immunological laboratory results from the day of 109 
admission.  Clinical parameters and tuberculin skin test results at admission were not 110 
captured routinely, as children were only enrolled after admission and a positive HIV test.   111 
 112 
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As per the local standard of care, investigations for pulmonary TB were performed on at 113 
least three samples of induced sputum or gastric washings, at the discretion of the treating 114 
clinician.  Patients were also investigated for other concurrent infections according to local 115 
standard protocols.
21
  Fluorescent microscopy was performed on sputum smears, followed 116 
by culture in mycobacterial growth indicator tubes.  Specimens that were smear positive 117 
and cultures that flagged positive were further subjected to polymerase chain reaction by 118 
line-probe assay (LPA; MTBDRplus, Hain Lifescience, Germany).  In-vitro drug sensitivity 119 
testing was performed for both first and second line anti-tuberculosis drugs. The Xpert MTB-120 
RIF platform (hereafter referred to as Xpert) was introduced in late 2013, replacing sputum 121 
smear microscopy.  122 
 123 
 124 
Statistical analysis 125 
We present a descriptive analysis of all TB diagnoses in the MATCH study. TB-negative 126 
patients, bacteriologically-confirmed TB cases and clinically-diagnosed cases were compared 127 
using ANOVA (for continuously-distributed data) or chi-square (for categorical variables).  In 128 
addition, we assessed associations between patient characteristics (including laboratory 129 
results, TB sampling method and ART strategy) and the diagnosis of TB using a negative 130 
binomial logistic regression model comparing children with and without a confirmed 131 
diagnosis of TB; empirically-treated children were excluded from this model, as were any 132 
children with missing data.  We hypothesised that anaemia (Hb <10g/dL), leukocytosis 133 
(white cell count >12 x 10
9
), thrombocytosis (platelets >400 x 10
9
) and hypoalbuminaemia 134 
(<25g/L) might, as surrogate markers of inflammation, be associated with a diagnosis of TB 135 
(ESR and CRP levels were infrequently measured, and therefore were not included in the 136 
model).  Following univariate analysis, all variables were included in a fully-adjusted 137 
multivariate model. A parsimonious adjusted model was then reached via a backward 138 
stepwise approach, sequentially excluding variables whose p value was >0.1 and selecting a 139 
final model that minimised the Akaike information criterion. Results are presented as 140 
adjusted relative risks (aRR) with 95% confidence intervals (CI), and p values <0.05 were 141 
considered significant.  All analyses were performed using SPSS version 22 (IBM).   142 
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 143 
Ethics 144 
Written informed consent was obtained from the caregivers of all children enrolled in the 145 
MATCH study. The trial was approved by the Biomedical Research Ethics Committee of the 146 
University of KwaZulu Natal and King Edward VIII Hospital.   147 
 148 
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RESULTS 150 
Descriptive analysis 151 
We enrolled 82 children in the MATCH trial.  Figure 1 outlines the recruitment and TB 152 
diagnostic process, while Table 1 outlines the patients’ baseline characteristics and sites of 153 
TB.  The mean age at admission was 23 months, 46.3% (n = 38) were girls, the mean CD4 154 
percentage was 17.46% and 21.95% (n = 18) presented with oedematous malnutrition.   155 
Seventy five children were investigated for TB and 21/82 (25.6%) were determined to have 156 
TB.  Eight (10.9%) had bacteriologically confirmed pulmonary TB (one of whom died before 157 
the culture flagged positive) while thirteen were clinically diagnosed. Eight were treated 158 
empirically after admission, while five were on treatment at enrolment but had no positive 159 
TB results on record.  All six culture-positive TB isolates were fully sensitive in vitro.   160 
62 patients had sputum samples, while the remaining 13 had gastric aspirates. The mean 161 
ages of those with sputum or gastric aspirate samples did not differ significantly (25 versus 162 
21 months, p = 0.7). No gastric aspirate samples tested positive for TB; two empirically-163 
treated patients had had gastric aspirate samples tested. Xpert was employed in 45 164 
patients, but was only positive in two, both of whom were subsequently culture positive.  Of 165 
the 37 patients enrolled before Xpert was widely available, five had confirmed TB and seven 166 
were empirically treated, versus three confirmed and six empirically treated after Xpert was 167 
introduced (p=0.199).  Thus, the introduction of Xpert did not appear to affect the rates of 168 
empiric treatment for TB in smear-negative patients, though it should be underlined that 169 
this study was carried out while local clinicians were still familiarising themselves with Xpert.   170 
One empirically-treated child was suspected of having TB meningitis clinically and on 171 
cerebrospinal fluid analysis (leukocytosis and elevated protein levels), but was TB culture 172 
negative from all specimens. The remainder of those commenced on empiric treatment at 173 
our centre were suspected of having pulmonary TB.  Prior to their admission to KEH, two 174 
children were on treatment for suspected pulmonary TB, two for suspected disseminated 175 
TB, and one for suspected abdominal TB.  In addition, one child underwent an axillary lymph 176 
node biopsy which led to a diagnosis of Bacille Calmette-Guérin (BCG) IRIS; this child was not 177 
classified as having TB in this study. 178 
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Regression analysis 179 
Fifty-three children had sufficient data for inclusion in the multivariate analysis, including 7 180 
of those with proven TB (the eighth child, who was smear-positive but culture-negative, was 181 
excluded for lack of a full blood count result). Results of the regression analysis are 182 
presented in Table 2.  While leukocytosis was associated with a slight increased risk of TB in 183 
the final model (aRR 1.81, 95% CI 1.067—1.308), thrombocytosis was unexpectedly 184 
associated with a reduced risk (aRR 0.868, 95% CI 0.774—0.974).  The diagnosis of a culture-185 
proven bacterial infection during the admission was associated with a reduced risk of TB 186 
(aRR 0.856, 0.748—0.979).  Sputum sampling (as opposed to gastric washings) was 187 
associated with a 13.4% increased risk of subsequent diagnosis of TB (95% CI 2.1%—26%).  188 
While allocation to the “delayed ART” group was associated with a 13.8% increased risk of 189 
TB in the full model, this association disappeared when the parsimonious model was 190 
created and it was omitted from the final model.  There was a small reduction in risk for 191 
children with CD4 percentages between 20—25% (aRR 0.864, 95% CI 0.765—0.976 with CD4 192 
percentage >25% used as the reference category), but no other CD4 values were associated 193 
with either increased or decreased risk.   194 
 195 
  196 
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DISCUSSION 197 
In our prospective cohort of 82 HIV-infected South African children, admitted to a university 198 
teaching hospital for the management of complicated SAM, we found a 25.6% incidence of 199 
TB within the first month of admission, with bacteriological confirmation in 38% of cases (n 200 
= 8/21).   201 
Children with HIV often present with paucibacillary TB disease that defies culturing, sample 202 
acquisition is difficult (particularly in the case of extrapulmonary TB) and malnutrition is a 203 
component of most clinical diagnostic scoring systems, rendering these less reliable in a 204 
population of malnourished children.
22
  We found few associations between routine 205 
laboratory parameters and culture-proven TB.  Ultimately our best regression model was 206 
still not a particularly good fit for the data, likely due to unmeasured confounders and a lack 207 
of clinical and radiological details, and the associations we identified were not strong 208 
enough to be useful in a predictive model.  Further studies are required to identify 209 
biomarkers of active TB that are reliable in severely-malnourished, HIV-infected children.
23
     210 
In the regression model, sputum sampling was associated with a diagnosis of TB when 211 
compared with gastric aspirates, which is consistent with previous studies showing superior 212 
sensitivity of sputum sampling.
24
  Some of the other associations that we identified require 213 
a nuanced interpretation.  The association of delayed ART and TB was seen in the fully 214 
adjusted model but not the final parsimonious model, and is not likely to be a true 215 
association, as all but one positive sputum sample were acquired during the first week of 216 
admission—i.e. early ART would not have prevented these diagnoses of TB.  In addition, 217 
randomisation was stratified by TB status at enrolment.  Possibly this finding indicates 218 
sampling bias by clinicians in this open-label study.  The strongest conclusion one could 219 
draw is that the lack of increased risk of TB following early ART assuages concerns regarding 220 
immune reconstitution inflammatory syndrome (IRIS) reactions in these children.     221 
Culture-proven bacterial infection was associated with a 14.4% reduced risk of culture-222 
proven TB—not only is it exceedingly unlikely that bacterial infections are protective against 223 
mycobacterial infections, but multiple simultaneous opportunistic infections are in fact 224 
expected in severely immunosuppressed children.  It is more likely that treatment for 225 
bacterial infections led to false-negative TB samples, or that treatment for TB resulted in 226 
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false-negative bacterial cultures.  Broad-spectrum antibacterials—empiric or otherwise—227 
were frequently administered to the children in this study, as SAM is frequently associated 228 
with infections at time of presentation, and hospital-acquired infections are also common in 229 
this patient group.
21
  While the local formulary dictates that quinolones only be prescribed if 230 
indicated by antibiotic susceptibility profiles or on the advice of the infectious diseases 231 
service, aminoglycosides are frequently employed (benzylpenicillin and gentamicin are first-232 
line empiric therapy for severely unwell children in this institution), as were carbepenems,
21
 233 
both of which have activity against TB.
25
  We were unable to access the original charts for 234 
most patients, meaning that we could not correlate actual antibiotic prescriptions with the 235 
likelihood of a TB diagnosis.  However, it is reasonable to assume that TB diagnoses could be 236 
masked by the treatment of other infections (or vice versa) in severely unwell children with 237 
HIV and SAM, or not considered when a child with SAM presents to hospital with a sepsis-238 
like syndrome and therefore it would be advisable to include TB investigation as part of the 239 
standard admission workup in order to minimize the risk of false negatives in the acute phase 240 
of malnutrition management.   241 
This is, to our knowledge, the first study describing TB in children who all have both HIV and 242 
SAM. Looking beyond the multivariate model in a subset of patients, there were 13 243 
additional patients in this study who were empirically treated for TB.  The true rate of TB in 244 
children with SAM and HIV remains unquantifiable as long as so many cases remain 245 
unconfirmed.  Table 3 summarises a sample of studies of such populations
26,27
: while the 246 
rate of confirmed TB in children with SAM appears to rise in parallel with increasing rates of 247 
HIV (allowing for local variation in baseline TB rates), rates of empiric treatment vary 248 
substantially.  Thus, it is impossible to assess the separate contributions of HIV and SAM to 249 
the pathogenesis of TB in children, though Table 3 does suggest that HIV is a key risk factor 250 
for TB in SAM—with increasing numbers of malnourished children now having HIV as an 251 
underlying cause, it is important for clinicians to particularly consider TB in such cases.  Our 252 
own study shows that, despite the inherent challenges, microbiological confirmation of 253 
suspected pulmonary TB is possible in severely malnourished children with HIV.   254 
Other studies in Africa have started with a diagnosis of TB and looked backwards for 255 
associations with malnutrition and/or HIV, usually finding strong and independent 256 
associations with both of these risk factors and TB mortality.
12,13,28
  The only other studies 257 
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that we can find that began with malnourished children and looked for associations with TB 258 
were carried out in South Asia, where paediatric HIV prevalence is far lower, and differ in 259 
many important methodological factors from our study.
29,30
  One such study examined 405 260 
severely malnourished Bangladeshi children with respiratory symptoms and radiographic 261 
pulmonary infiltrates: 7% had confirmed TB and a further 16% were treated based on 262 
clinical suspicion.
30
  HIV prevalence was not determined, but was known to be rare in that 263 
locale. While this study is important in raising awareness of TB mimicking acute pneumonia 264 
in children with SAM, the TB prevalence in a select population with radiologic changes will 265 
obviously be higher than the TB prevalence in malnourished children in general.   266 
Strengths of our study include prospective recruitment of patients and access to tertiary-267 
level diagnostic facilities.  Limitations include the relatively small number of patients, 268 
missing data, practice changes during the course of the trial (eg. the introduction of Xpert) 269 
and the single-centre setting, limiting the generalisability to other settings in sub-Saharan 270 
Africa and beyond.  Poor availability of patients’ original hospital files meant that we lacked 271 
data regarding clinical findings, radiographs and tuberculin skin tests, which would have 272 
been a useful addition to our analysis.  We considered our two patients who were smear-273 
positive but culture negative to have confirmed TB, in keeping with the WHO classification,
20
 274 
but these may have been false positives due to non-tuberculous mycobacteria—equally, we 275 
considered patients who started treatment in other centres to be empirically-treated, when 276 
they may in fact have had a confirmed diagnosis which was not identifiable on the national 277 
laboratory online system.   278 
 279 
  280 
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CONCLUSIONS 281 
TB is very common in HIV-infected children with severe acute malnutrition.  While 282 
microbiological confirmation of the diagnosis is feasible, numerous diagnostic challenges—283 
including suboptimal testing (gastric aspirates as opposed to induced sputum) and false 284 
negative TB diagnostics (with prior antibacterial therapy)—mean that empiric treatment 285 
remains common in this patient group.  Future studies should focus on diagnostic strategies 286 
that are sufficiently robust for this important, vulnerable population of children in resource-287 
poor settings.  With SAM being increasingly seen in conjunction with HIV in sub-Saharan 288 
Africa, it is important that TB diagnosis and treatment be integrated into the programmatic 289 
management of these conditions.   290 
 291 
  292 
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Figure 1: Recruitment and diagnostic process 387 
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82 children admitted to KEH with SAM and newly 
diagnosed with HIV enrolled in the MATCH study 
71 smear negative patients 
awaited culture results 
7 patients not tested 
10 patients 
commenced 
empiric treatment 
5 patients 
continued empiric 
treatment 
 63 patients not treated 
4 positive sputum 
cultures (2 were already 
on empiric treatment) 
77 children not on TB 
treatment developed SAM 
4 smear-positive patients 
(2 from microscopy,  
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 1 child died 
2 positive sputum cultures  
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 TB negative (n = 
61) 
 Bacteriologically 
confirmed (n = 8) 
Clinically diagnosed 
(n = 13) 
p
 
 
BASELINE CHARACTERISTICS     
Age (months) 19 ± 22 29 ± 41 36 ± 40 0.1 
Female 28 (45.9%) 5 (62.5%) 5 (38.5%) 0.56 
Oedema present 12 (19.7%) 4 (50%) 2 (15.4%) 0.12 
Early ART (<2 weeks) 29 (47.5%) 3 (37.5%) 6 (46.2%) 0.87 
Other bacterial infection 33 (54.1%) 3 (37.5%) 3 (23.1%) 0.1 
CD4 (cells/μL) (n = 73) 945 ± 807 874 ± 309 721 ± 214 0.49 
CD4 percentage (n = 73) 18.35 ± 9.1% 15.5 ± 9.83% 14.5 ± 11.4% 0.4 
Haemoglobin (g/dL) 8.65 ± 2.0 8.7 ± 3.8 8.4 ± 1.7 0.73 
Haemoglobin <7 9 (14.8%) 3 (37.5%) 2 (15.4%) 0.27 
Platelets (x 10
9
/L) 336 ± 208 336 ± 215 297 ± 131 0.81 
Platelets >400 20 (32.8%) 1 (12.5%) 4 (30.8%) 0.6 
Albumin (g/L) 24 ± 8 21 ± 5 23 ± 6 0.56 
Albumin <25 30 (29.2%) 6 (75%) 8 (61.5%) 0.35 
CRP (mg/L) (n = 37) 38 ± 49 38 ± 41 57 ± 35 0.68 
CRP >10 (n = 37) 16 5 5 0.17 
SITE OF TB     
Pulmonary - 7 8 - 
Pulmonary + Disseminated - 1 3 - 
Meningitis - 0 1 - 
Abdominal - 0 1 - 
DIAGNOSIS     
Smear microscopy - 2* - - 
Xpert - 2† - - 
Culture - 6 - - 
Table 1: Baseline characteristics of the patients in this study. 389 
Values are given as mean ± SD or n (%) as appropriate. P values are for a three-way 390 
comparison.  Bacterial infection refers to any positive blood/sputum/urine culture for 391 
pathogenic bacteria within the first month of admission.   392 
*Both were smear positive but culture negative 393 
†Both were culture positive 394 
 395 
 396 
  397 
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Table 2: Results of regression analysis. Data are presented as: (a) n (%); (b) median (IQR); (c) RR (95% CI)  400 
Risk factor 
TB No TB Unadjusted
c
 p 
(Wald) 
Fully adjusted
c
 p 
(Wald) 
Parsimonious adjusted
c
 p 
(Wald) 
Total (n = 53) 7 46       
Sex
a
: Male 3 (42.9%) 24 (52.2%) 0.963 (0.82—1.131) 0.645 1.041 (0.933—1.162) 0.467 - - 
        Female 4 (57.1%) 22 (47.8%) 1 - 1 - - - 
Delayed ART
a
 5 (71.4%) 22 (47.8%) 1.101 (0.942—1.286) 0.229 1.138 (1.003—1.291) 0.044 - - 
Early ART 2 (28.6%) 24 (52.2%) 1 - 1 - - - 
Oedema present
a
 3 (42.9%) 11 (23.9%) 1.101 (0.904—1.341) 0.337 1.052 (0.904—1.247) 0.464 - - 
No oedema 4 (57.1%) 35 (76.1%) 1 - 1 - - - 
Hb <10g/dL
a
 3 (42.9%) 12 (26.1%) 0.921 (0.761—1.114) 0.397 0.870 (0.740—1.023) 0.092 0.875 (0.756—1.014) 0.075 
Hb ≥10g/dL 4 (57.1%) 34 (73.9%) 1 - 1 - 1 - 
WBC >12
 
x 10
9 a
 7 (100%) 29 (63%) 1.194 (1.072—1.331) 0.001 1.199 (1.057—1.359) 0.005 1.181 (1.067—1.308) 0.001 
WBC ≤12 x 10
9
 0 17 (37%) 1 - 1 - 1 - 
Platelets ≥400 x 10
9 a
 1 (14.3%) 14 (30.4%) 0.921 (0.789—1.076) 0.299 0.825 (0.730—0.932) 0.002 0.868 (0.774—0.974) 0.016 
Platelets <400 x 10
9
 6 (85.7%) 32 (69.6%) 1 - 1 - 1 - 
Albumin <25g/L
a
 5 (71.4%) 26 (56.5%) 1.065 (0.91—1.245) 0.434 0.940 (0.788—1.120) 0.486 - - 
Albumin ≥25g/L 2 (28.6%) 20 (43.5%) 1 - 1 - - - 
CD4 <15%
a
 4 (57.1%) 18 (39.1%) 1.064 (0.845—1.338) 0.599 1.039 (0.899—1.201) 0.604 1.082 (0.927—1.264) 0.317 
CD4 15—20% 2 (28.6%) 12 (26.1%) 1.029 (0.805—1.314) 0.821 0.914 (0.760—1.100) 0.343 0.985 (0.822—1.181) 0.87 
CD4 20-25% 0 8 (17.4%) 0.900 (0.748—1.083) 0.264 0.806 (0.690—0.942) 0.007 0.864 (0.765—0.976) 0.019 
CD4 >25% 1 (14.3%) 8 (17.4%) 1 - 1 - 1 - 
Any positive bacterial culture
a
 2 (28.3%) 24 (52.2%) 0.909 (0.777—1.062) 0.229 0.844 (0.752—0.948) 0.004 0.856 (0.748—0.979) 0.024 
No positive bacterial culture 5 (71.7%) 22 (47.8%) 1 - 1 - 1 - 
Sampling site: Sputum
a
 7 (100%) 37 (80.4%) 1.159 (1.056—1.272) 0.002 1.115 (0.989—1.256) 0.076 1.134 (1.021—1.260) 0.019 
Gastric washings 0 9 (19.6%) 1 - 1 - 1 - 
Age (months) (Median, IQR)
b
 15 (8—42) 18 (6.75—27) 1.001 (0.998—1.005) 0.463 1.002 (0.999—1.005) 0.151 - - 
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Study Year Setting Number 
with SAM 
Prevalence 
of HIV
a
 
Prevalence of 
confirmed TB
a
 
Prevalence of empiric 
TB treatment
a
  
Overall rate of TB 
treatment
a
 
Cartmell (Part 1)
26
 1983 Maputo, 
Mozambique 
833 0 53 (6.4%) 29 (3.5%) 81 (9.7%) 
Cartmell (Part 2)
26
  2001 Maputo, 
Mozambique 
558 65 (29.3%)* 78 (14%) 14 (2.5%)  92 (16.5%) 
De Maayer
27
 2011 Johannesburg, 
South Africa 
113 58 (51%) 3 (2.6%) 29 (25.7%) 32 (28.3%) 
This study 2016 Durban, South 
Africa 
82 82 (100%) 8 (9.8%) 13 (15.9%) 21 (25.6%) 
Table 3: Examples of other studies of children admitted for the management of SAM in different sub-Saharan African settings.  These data suggest that, as 401 
rates of HIV increase, so too do rates of bacteriologically confirmed TB in children with SAM—however, rates of empiric treatment differ markedly between 402 
studies and confound accurate assessment.   403 
(a) n (%)  404 
*51 with an AIDS-defining-illness, 14 with confirmed HIV. An additional 30 had suspected HIV but this was not confirmed (not included in this table) 405 
 406 
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